Carl Zeiss MicroImaging Inc., a leading provider of microscopy solutions for a variety of research, clinical and industrial applications, introduces its Laser TIRF 3 microscope system, designed to enable visualization of near-cell membrane dynamic processes while maintaining optimum specimen incubation conditions.

The Laser TIRF 3 also allows observation of single molecule dynamic processes in cell-free systems and, in combination with other techniques such as atomic force microscopy (AFM), the new microscope provides a complete solution for users in the life sciences, biochemistry, molecular biology and biophysics arenas.
The Laser TIRF 3 maintains Carl Zeiss' long-standing commitment to system flexibility. A range of incubation options maintain viable conditions for live cell experiments. Together with the 'definite focus' module, users can be assured of accurate quantitative data over long time periods. The new laser module may be equipped with up to four solid-state lasers, is AOTF-controlled (acousto-optical tuneable filter) and may be operated entirely from the AxioVision software interface.
The TIRF slider is available in two versions; either manual or fully-motorized and software controllable. The motorized version permits a given illumination angle to be set with significantly greater accuracy and speed than other current systems and the reproducible angle setting results in reproducible penetration depths for the light beam. Together with the corrected beam-path and special filter sets, the apochromatically-corrected optics of the TIRF slider guarantee maximum image quality.
AOTF control and angle setting are integrated into the 'fast image acquisition' module of the AxioVision software, enabling significantly more high resolution images to be acquired within any given timeframe.
The new Laser TIRF 3 builds on the attributes of the Laser TIRF, the first microscope to offer the combination of TIRF and transmitted-light contrasting techniques, such as DIC and brightfield, and enable the sequential recording of image pairs. By selectively exciting cellular fluorophores adsorbed, adhered, or bound to the surface and combining it with conventional epi-fluorescence, researchers can relate surface effects to internal cellular structures.

For more information: www.zeiss.com/micro


Related Content

News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | Computed Tomography (CT)

A new study shows large increases in the use of computed tomography (CT) scans of the head in emergency departments ...

Time December 05, 2025
arrow
News | X-Ray

Dec. 1, 2025 – Zwanger-Pesiri Radiology, one of the most respected and technologically advanced outpatient radiology ...

Time December 03, 2025
arrow
News | Interventional Radiology

Dec. 1, 2025 — GE HealthCare has unveiled the Allia Moveo,1 an image guiding solution designed to enhance mobility and ...

Time December 02, 2025
arrow
News | Archive Cloud Storage

Nov. 30, 2025 — Gradient Health, Inc. has released Atlas 2, a major upgrade to its self-service medical imaging data ...

Time December 01, 2025
arrow
News | Artificial Intelligence

Nov. 24, 2025 — Siemens Healthineers is launching artificial intelligence-enabled services to help healthcare providers ...

Time November 24, 2025
arrow
News | Artificial Intelligence

Nov. 20, 2025 — Aidoc has announced a collaboration with AdventHealth to launch one of the largest imaging AI ...

Time November 21, 2025
arrow
News | Radiology Business

Nov. 13, 2025 — Covera Health recently announced that Advanced Radiology Services (ARS) has joined its national Quality ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Orthopedic Imaging

Nov.10, 2025 — Medical imaging technology company Adaptix Ltd. has received 510(k) clearance from the U.S. Food and Drug ...

Time November 11, 2025
arrow
Subscribe Now